Of course, extrapolation of this evidence of cancer from rodent to human is very uncertain. Such an extrapolation would only hold true if human studies also showed an increase in cancer rates. And in fact that is what scientists are showing. Evidence from the cholesterol-lowering trial known as CARE (Cholesterol And Recurrent Events) showed that Pravachol (cholesterol-lowering drug made by Bristol-Myer Squib) prevented the chances of suffering from a heart attack by 1.1%. This miniscule benefit was accompanied with an increase in breast cancer among women. Among the group taking Pravachol, 13 cases of breast cancer were reported. Conversely, there was only one case of breast cancer among non-users of Pravachol.
That cholesterol lowering drugs can potentially cause cancer will never be main stream. Drug company funded studies for cholesterol-lowering drugs are very short in nature. Considering that it takes a significant amount of time for cancer to develop this side effect will continue to fly below the radar.
The list of negative side effects from cholesterol-lowering drugs continues. Researchers from the University of Denmark report that about 15% of cholesterol lowering drug users over the age of 50 will suffer from nerve damage as direct result of using statin drugs. USA Today reported, "Statins have killed and injured more people than the government has acknowledged".
About the Author: Shane holds a Master's degree in organic chemistry and has first hand industry experience with drug research, design and synthesis. He knows American's want and deserve natural medicine not
prescriptions. Visit www.health-fx.net and for his book
www.healthmyths.net
|